Qiagen stock: buy or sell?
February 27th, 2020
QIAGEN N.V. provides sample to insight solutions that transform biological materials into molecular insights worldwide. It offers sample technologies for plasmid deoxyribonucleic acid (DNA) purification, ribonucleic acid purification and stabilization, genomic and viral nucleic acid purification, DNA cleanup after polymerase chain reaction (PCR) and sequencing, and library preparation for sequencing applications; and assay technology solutions.
Should I buy Qiagen stock?You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. Having a trading strategy helps to make decisions easier, quicker and with less hesitations. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.
Just 1 of our buy setups matches with Qiagen stock now:
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||Yes|
|100d MA crossing up 200d MA||No|
Is Qiagen stock a buy?
Financial institutions and banks post stock ratings everyday.Unfortunately, we couldn't detect any rating for QGEN stock for the last 30 days.
Qiagen stock analysis
Qiagen shares broke up the SMA line of 200 days today and closed at $36.47, climbed a 3.93%.
Qiagen broke up the simple moving average line of 200d today and closed at $36.47, climbed a 3.93%. Since December when SMA50d and SMA100d crossed up, QGEN price slipped $-4.69 per share (-11.39%).
Qiagen closed this week at $36.47 and dropped a rough -2.43%.
Since mid February when QGEN stock price broke up the SMA40w line, it gained $0.99 (2.79%).
Qiagen stock price history
Qiagen stock went public on June 28th, 1996 with a price of $1.931. Since then, QGEN stock grew a 1,789.60%, with a yearly average of 77.80%. If you had invested $1,000 in Qiagen stock in 1996, it would worth $17,896.00 today.
1: Adjusted price after possible price splits or reverse-splits.
Qiagen stock historical price chart
QGEN stock reached 52-week highs on December at $43.16, and all-time highs 2000-07-17 with a price of 58.18.
Qiagen stock price targetNobody can reliably foresee how stock prices may evolve in the future. However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. You should not follow the analysts' QGEN stock price predictions in the hope that they will be met as they may be wrong and not met. For the last 30 days we have not detected any price prediction for Qiagen stock by any trusted analyst.
Financials and fundamental analysis
Earnings date and Earnings per ShareSince May, when Qiagen published its last earnings report, it . Unfortunately, reported EPS is not yet available in our database.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsCompared to 2017, last anual sales report draw a decent gain of 5.95% to $1,501.85 M USD. Instead, its profit margin (compared to sales) jumped to 12.68%, that is $190.38 million. To have an updated picture of the financial situation of Qiagen, we have calculated the trailing twelve month (TTM) sales and income figures. TTM values are the sum of the last 4 quarters and aproximate to an annual fiscal report ending in 2019-Q1 that can be compared to 2018 fiscal year results. Annual Qiagen TTM sales up to were $1,158.28 and income was $158.09 million USD. If we compare this TTM figures with the last reported annuality, we can esteem Qiagen business evolution since December 2018: Annual sales up to , compared to lastest yearly report, plunged a hair-raising -22.88%. Nonetheless, profit margin (net income/sales) remained constant at 12.68%.
|2013||$1,300 M||-||$69 M5.3%||-|
|2014||$1,345 M||3.44%||$117 M8.7%||68.86%|
|2015||$1,281 M||-4.74%||$127 M9.9%||8.98%|
|2016||$1,338 M||4.45%||$80 M6.0%||-36.74%|
|2017||$1,418 M||5.95%||$40 M2.8%||-49.76%|
|2018||$1,502 M||5.95%||$190 M12.7%||371.31%|
|TTM||$1,158 M||-22.88%||$158 M13.6%||-16.96%|
Quarterly financial resultsQiagen reported million in sales for 2019-Q1, a -100.00% decline compared to previous quarter. Reported quarter income marked M with a profit margin of . Profit margin remained steady a 0.00% compared to previous quarter when profit margin was 15.12%. When comparing sales to same quarter last year, Qiagen sales marked a dreadful drop down and collapsed a -100.00%.
|2017-Q1||$308 M||-||$18 M5.7%||-|
|2017-Q2||$349 M||13.42%||$14 M4.0%||-20.96%|
|2017-Q3||$364 M||4.29%||$48 M13.3%||247.56%|
|2017-Q4||$397 M||9.04%||$-40 M-10.0%||-181.87%|
|2018-Q1||$344 M||-13.43%||$32 M9.4%||-181.36%|
|2018-Q2||$377 M||9.79%||$37 M9.8%||14.00%|
|2018-Q3||$378 M||0.19%||$60 M16.0%||63.85%|
|2018-Q4||$403 M||6.68%||$61 M15.1%||1.04%|
Qiagen ownershipWhen you are planning to buy a stock, it's always worth to have a look its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Qiagen, 2.74% of all outstanding shares are owned by its staff.
In case of Qiagen stock, 72.11% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for QGEN stock account 0.00%, no big difference from last month.
For a better context understanding, the next table shows ownership data compared to other related stocks:
|Market cap||$8.3 B|
|Total shares||227.8 M|
|Float shares||219.7 M|
|- Institutional holdings (%)||72.1%|
|- Insider holdings (%)||2.7%|
|Shares in short selling||0.0%|
|Thursday, February 27th, 2020|
|Day range||$35.84 - $37.60|
|Average true range||$0.84|
|50d mov avg||$35.85|
|100d mov avg||$35.18|
|200d mov avg||$36.10|
Qiagen performanceTo better understand Qiagen performance you must compare its gains with other related stocks in same sector or industry. We compared Qiagen against in the following table: